During the past decade, Fraser Clinical Trials Inc. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fraser Clinical Trials Inc." #1 sponsor was "Bayer" with 3 trials, followed by "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fraser Clinical Trials Inc." #1 collaborator was "Alberta Innovation and Science" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "GE Healthcare" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fraser Clinical Trials Inc." are "Crohn Disease" (5 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Fraser Clinical Trials Inc." in a lesser frequency.

Most popular intervention types in "Fraser Clinical Trials Inc." are "Drug" (18 trials), "Other" (7 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ozanimod" (3 trials), "Antiplatelet Drug" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fraser Clinical Trials Inc." are 21 trials for "All" genders.

Currently, there are NaN active trials in "Fraser Clinical Trials Inc.". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fraser Clinical Trials Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fraser Clinical Trials Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".